SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma gets USFDA nod for generic cardiac tablets

01 Aug 2011 Evaluate

Sun Pharmaceutical Industries had received tentative approval from the US health regulator for its generic clopidogrel tablets used for treating heart ailments. United States Food and Drug Administration (USFDA) have granted the company's subsidiary a tentative approval for its abbreviated new drug application (ANDA) for generic clopidogrel tablets USP.

The generic clopidogrel tablets USP in the strength of 75 mg are equivalents of Sanofi Aventis's Plavix tablets. Clopidogrel tablets USP have annual sale of about $6 billion in America. The tablets are indicated for the treatment of acute coronary syndrome, recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease.crackcrack

Sun Pharma Inds. Share Price

1845.90 -26.50 (-1.42%)
12-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.90
Dr. Reddys Lab 1270.10
Cipla 1292.00
Zydus Lifesciences 930.75
Lupin 2246.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×